FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 鷹美(國際)控股有限公司 (於開曼群島註冊成立之有限公司) 呈交日期: 2025年9月1日 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02368 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 574,180,000 | | 0 | | 574,180,000 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 574,180,000 | | 0 | | 574,180,000 | 第 2 頁 共 10 頁 v 1.1.1 F ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對其準 確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而產生 或因倚賴該等內容而引致的任何損失承擔任何責任。 EAGLE NICE (INTERNATIONAL) HOLDINGS LIMITED 鷹 美 ( 國 際 ) 控 股 有 限 公 司* （於開曼群島註冊成立之有限公司） (股份代號: 02368) 於二零二五年八月八日舉行之 股東週年大會投票結果 董事會欣然宣佈，所有決議案已於二零二五年八月八日舉行之股東週年大會上以按股數 投票表決方式獲正式通過。 茲提述本公司於二零二五年七月十七日所刊發之通函（「通函」），就有關授出發行及購 回股份之一般授權、宣派末期股息、重選退任董事及股東週年大會通告。除文義另有界定 者外，本公佈所用詞彙與通函所界定者具相同涵義。 根據上市規則及公司章程，股東週年大會主席要求按股數投票表決於股東週年大會上提呈 之決議案。董事會欣然宣佈，提呈的普通決議案已於二零二五年八月八日舉行之股東週年 大會上以按股數投票表決方式獲正式通過，有關結果如下：- * 僅供識別 1 | | 普通決議案 ...

Group 1 - The chairman of the board, Zhong Yusheng, increased his stake in Eagle Beauty (02368) by 16,000 shares at a price of HKD 4.06 per share, totaling approximately HKD 65,000 [1] - After the purchase, the total number of shares held by Zhong Yusheng is 92,624,000, representing a holding percentage of 16.13% [1]

致：香港交易及結算所有限公司 截至月份: 2025年7月31日 狀態: 新提交 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02368 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 574,180,000 | | 0 | | 574,180,000 | | 增加 / 減少 (-) | | | 0 | | 0 | | | | 本月底結存 | | | 574,180,000 | | 0 | | 574,180,000 | 第 2 頁 共 10 頁 v 1.1.1 公司名稱: 鷹美(國際)控股有限公司 (於開曼群島註冊成立之有限 ...

Group 1 - The latest shareholder equity disclosures for Eagle Beauty (02368), Runmed-B (02297), and New Reach Holdings (08471) were made on July 31, 2025 [1] Group 2 - Eagle Beauty (02368) saw a slight increase in holdings from 92.568 million shares to 92.608 million shares, maintaining a holding percentage of 16.13% [2] - Runmed-B (02297) experienced a decrease in holdings from 99.025 million shares to 96.025 million shares, with the latest holding percentage at 6.85% compared to 7.07% previously [2] - New Reach Holdings (08471) had significant changes, with one shareholder reducing holdings from 114 million shares to 4.02 million shares, resulting in a holding percentage of 0%, down from 9.30% [2] - Another shareholder in New Reach Holdings increased holdings from 44.77 million shares to 155 million shares, achieving a holding percentage of 12.62%, up from 0.03% [2]

Group 1 - The chairman of the board, Zhong Yusheng, increased his stake in Eagle Beauty (02368) by purchasing 40,000 shares at a price of HKD 4.06 per share, totaling HKD 162,400 [1] - After the purchase, the total number of shares held by Zhong Yusheng is 92.608 million, representing a holding percentage of 16.13% [1]

Group 1 - The core point of the news is that Chen Xiaoying, an executive director of Eagle Beauty (02368.HK), increased his shareholding by purchasing 102,000 shares at an average price of HKD 3.9771 per share, totaling approximately HKD 405,700 [1] - Following this transaction, Chen Xiaoying's total shareholding increased to 36,950,800 shares, raising his ownership percentage from 6.42% to 6.44% [1]

Group 1 - The chairman of the company, Zhong Yusheng, increased his holdings in Eagle Beauty (02368) by 26,000 shares at a price of HKD 3.9992 per share, totaling approximately HKD 104,000 [1] - After the purchase, the latest number of shares held by the chairman is 92,568,000, representing a holding percentage of 16.12% [1]

Group 1 - The chairman of the company, Zhong Yusheng, increased his stake in Eagle Beauty (02368) by 26,000 shares at a price of HKD 3.9992 per share, totaling approximately HKD 104,000 [1] - Following the purchase, the chairman's total shareholding reached 92.568 million shares, representing a 16.12% ownership stake in the company [1]

Core Viewpoint - The company reported a significant revenue increase but a decline in profit, highlighting structural challenges in the global sportswear manufacturing industry due to capacity expansion and rising costs [1]. Group 1: Financial Performance - In 2024, the company's total revenue reached 4.437 billion RMB, a year-on-year increase of 17.99%, marking a historical high [1]. - Profit attributable to equity holders fell to 200 million RMB, a decrease of 17.57% year-on-year, with gross margin declining from 18.37% to 16.07% [1]. - The company's net profit margin decreased from 6.68% to 4.75%, average return on equity dropped from 16.44% to 13.04%, and total asset net profit margin fell from 8.44% to 6.08% [4]. Group 2: Cost and Capacity Expansion - The company's overseas capacity expansion in Southeast Asia has led to increased costs, with property, plant, and equipment rising from 923 million RMB to 1.218 billion RMB, an increase of 31.96% [3]. - Cash outflow for fixed asset purchases nearly doubled from 119 million RMB to 221 million RMB [3]. - Financing costs increased from 39 million RMB to 64 million RMB, and short-term loans surged from 590 million RMB to 1.207 billion RMB, raising the debt-to-asset ratio from 48.45% to 54.10% [3]. Group 3: Working Capital Management - Inventory rose from 639 million RMB to 888 million RMB, with inventory turnover remaining stable at 4.84 times [4]. - Accounts receivable increased by 122 million RMB, from 294 million RMB to 425 million RMB, while the accounts receivable turnover ratio remained high at 12.25 times [4]. - The current ratio decreased from 1.36 to 1.03, indicating increased liquidity pressure, with cash and cash equivalents dropping from 444 million RMB to 357 million RMB [4]. Group 4: Operational Efficiency - The company's earnings per share declined from 0.48 RMB in 2022 to 0.36 RMB in 2024, with profit attributable to equity holders decreasing from 256 million RMB to 200 million RMB [5]. - Administrative expenses rose from 279 million RMB to 329 million RMB, an increase of 17.92%, while sales and distribution expenses surged from 25 million RMB to 37 million RMB, a 48% increase [5]. - The company aims to optimize global supply chain configurations and adapt to changes in the international business environment, particularly concerning U.S. tariff policies [5].